Inactive Instrument
Sector Cell Therapeutics Inc Nasdaq
Stocks
US1509346029
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 26/06/23 | DRI Healthcare Trust Receives US$54.8 Million in Debt Repayment | MT |
| 26/06/23 | DRI Healthcare Trust Announces USD 54.8 Million Debt Repayment from CTI Biopharma Corp | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.56% | -3.38% | -5.16% | +8.53% | -0.11% | -1.83% | +8.00% | -30.00% | +196.63% | 45.63B | |
| -1.34% | -3.02% | -5.17% | +25.61% | +152.42% | +335.17% | +533.03% | +556.60% | - | 43.96B | |
| +2.23% | +4.49% | +12.27% | +51.83% | +20.16% | +45.64% | +27.93% | +4.76% | +247.91% | 43.73B | |
| -1.64% | -1.13% | -4.14% | +29.57% | +14.38% | +4.58% | +73.47% | -7.42% | +970.86% | 40.23B | |
| -0.73% | -4.72% | -11.69% | +2.60% | +2.97% | +8.55% | +37.89% | -17.91% | +133.45% | 31.86B | |
| -12.77% | -14.73% | -6.91% | +3.15% | - | - | - | - | - | 17.4B | |
| +3.65% | +3.35% | +2.28% | +30.63% | +8.73% | +23.03% | +118.13% | +240.86% | +1,935.02% | 16.62B | |
| +1.83% | +3.20% | +4.97% | +15.94% | +17.76% | +16.49% | +32.73% | -40.36% | +93.27% | 14.46B | |
| +0.52% | -3.16% | -5.15% | +44.26% | +36.30% | +78.59% | +30.79% | -38.18% | +234.67% | 13.04B | |
| +2.29% | +8.25% | +1.15% | +16.03% | -5.94% | +0.55% | -34.51% | -34.84% | +123.76% | 13.03B | |
| +0.01% | -0.04% | -0.15% | +28.68% | +22.90% | +40.02% | -1.86% | -45.41% | +163.58% | 11.33B | |
| +5.47% | +0.95% | +25.68% | +24.04% | +9.91% | -23.76% | - | - | - | 11.22B | |
| -5.82% | -7.08% | -11.38% | +10.28% | -22.05% | +30.89% | +470.86% | +183.53% | +943.94% | 10.02B | |
| -0.68% | +2.67% | -13.76% | +89.28% | +49.00% | +25.51% | +55.74% | -53.48% | - | 10.73B | |
| -2.80% | -1.49% | -9.37% | +27.83% | +64.60% | +146.25% | +703.13% | +209.36% | +979.28% | 9.56B | |
| -3.08% | -4.77% | -8.64% | +29.59% | +42.55% | +134.60% | +482.26% | +70.67% | - | 9.53B | |
| -4.33% | -10.55% | -16.23% | +19.18% | +6.97% | +679.46% | +1,412.18% | +6.64% | - | 9.23B | |
| -4.76% | +4.45% | +30.14% | +148.69% | +160.71% | +86.31% | +71.69% | -2.62% | +1,195.20% | 9.48B | |
| -6.49% | -14.38% | -17.18% | -34.35% | -38.62% | -20.53% | +13.16% | +31.37% | +57.34% | 8.55B | |
| Average | -1.47% | -1.22% | -2.02% | +30.07% | +30.15% | +89.42% | +237.33% | +60.80% | +559.61% | 19.45B | |
| Weighted average by Cap. | -0.89% | -1.64% | -1.85% | +27.41% | +34.08% | +82.68% | +181.86% | +83.99% | +500.12% |
- Stock Market
- Stocks
- CTIC Stock
- Stock
- Sector Cell Therapeutics Inc
Select your edition
All financial news and data tailored to specific country editions
